Stock Price
4.28
Daily Change
0.15 3.63%
Monthly
19.22%
Yearly
143.18%
Q2 Forecast
4.04

EDAP TMS reported EUR8.81M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AngioDynamics USD 36.57M 3.79M Sep/2025
Boston Scientific USD 1.78B 53M Mar/2026
EDAP TMS EUR 8.81M 1.57M Sep/2025
Henry Schein USD 809M 1000K Mar/2026
Medtronic 2.97B 159M Sep/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Veracyte USD 50.84M 7.53M Mar/2026